Federal regulators said that a billionaire biotech founder's cancer drug claims were misleading. Federal regulators said that a billionaire biotech founder's cancer drug claims were misleading. The list below presents information on medications indicated for managing nausea and vomiting. This list is not all-inclusive; it does not include medications indicated for pregnancy-related. Physicians reassuring patients that their symptoms are normal may lead patients to infer treatment is not necessary. Complete response reported in 75 percent of patients with BCG-unresponsive, non-muscle-invasive bladder cancer. Targeted therapies yielded superior outcomes compared with chemoimmunotherapy in patients with chronic lymphocytic leukemia (CLL) who had previously received both B-cell receptor inhibitors (BCRi. Survey study compared facilitators and barriers to lymphoma clinical trial participation for non-Hispanic White, Hispanic, and African American and male and female patients. Obecabtagene autoleucel demonstrated superior remission and survival outcomes compared with standard non-CAR T-cell therapies in adults with relapsed or refractory B-cell acute lymphoblastic. After the cancer diagnosis: What do you say—and do—next? The most important thing, say the experts interviewed for this article, is for oncology nurses to reassure patients that they are not. The FDA has granted Priority Review to D-PLEX100, an investigational prolonged-release local doxycycline product aimed at reducing surgical site infections in patients undergoing abdominal. Pretreatment blood signatures in patients with diffuse large B-cell lymphoma (DLBCL) may indicate the likelihood of successful chimeric antigen receptor (CAR) T-cell therapy outcomes and could.